RxDoctor Payments Data

Ella Lynch

Psychiatric/Mental Health · Pembroke, NCNPI 1184611139

Payments from drug & device makers

$3,840in general payments, 2019–2025

Across 242 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$379
  • Supernus Pharmaceuticals, Inc.$291
  • Teva Pharmaceuticals USA, Inc.$252
  • Alkermes, Inc.$226
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$197
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,835100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,840 in reported general payments places this provider in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Medicare billing

Part B allowed, 2024
$16,193
Medicare patients
46
Services billed
165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl66$101,784
RexultiBrexpiprazole36$73,761
Invega SustennaPaliperidone Palmitate13$30,846
NuedextaDextromethorphan Hbr/Quinidine12$21,842
Lurasidone Hcl14$14,795
VyvanseLisdexamfetamine Dimesylate31$11,868
Vilazodone Hcl56$6,358
PristiqDesvenlafaxine Succinate14$6,173
Paliperidone ErPaliperidone43$5,786
QuviviqDaridorexant Hcl11$5,170
Asenapine Maleate19$4,551
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine30$4,279
Doxepin Hcl91$2,852
Aripiprazole38$2,313
Hydroxyzine Hcl64$2,165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,193$101,78466 claims
Otsuka America Pharmaceutical, Inc.Rexulti$379$73,76136 claims
Johnson & JohnsonInvega Sustenna$156$30,84613 claims
Avanir Pharmaceuticals, Inc.Nuedexta$53$21,84212 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$132$11,86831 claims
Idorsia Pharmaceuticals US IncQuviviq$46$5,17011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Pembroke

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →